What Challenges Do Patients with Hemophilia Face?


Robert F. Sidonio Jr, MD, assistant professor of pediatrics at Emory University, Children's Healthcare of Atlanta, gives an overview of the challenges associated with hemophilia management.

Robert F. Sidonio Jr, MD, assistant professor of pediatrics at Emory University, Children's Healthcare of Atlanta, gives an overview of the challenges associated with hemophilia management.


The challenges haven’t changed in general. It’s been a couple of things. Obviously, there’s the psychosocial aspect of missing out and not being able to participate in the same things as their friends, having to carry therapy everywhere they go, missing out on things because they have a bleeding event because they have to rest.

The biggest challenge hasn’t changed. It used to be viral contamination, that’s been almost completely eliminated as a risk through advancements in technology. The biggest issue is this issue with antibodies, neutralizing antibodies, against the factor. In severe hemophilia A, one-third of the patients will develop these neutralizing antibodies. So, a therapy that was once useful for them becomes totally useless. And so, when they infuse the factor becomes completely chewed up by the body and it attacks it like it’s a foreign substance and removes it. So then they have to use less efficacious therapies, like bypassing agents, to treat it. We have to give therapies, instead of every other day or every 3 days, we have to do therapies every day, and we may have to do that for years to get rid of the inhibitor. That still is the biggest challenge and that leads to all sorts of problems. Crippling joint disease, and so they have repeated joint bleeds. Over time, that joint loses its flexibility and becomes completely locked up. And obviously that would come with a lot of chronic pain issues. And so, that leads to depression, anxiety, and it’s just this complete spiral downward of effects related to inhibitors and joint bleeding.

So hopefully now we have some new therapies that better address those, and hopefully the next generation doesn’t have to deal with those issues. The other issue is when you have a high titer inhibitor, your rate of spontaneous bleeds goes up tremendously. You could trip in the shower and hit your head on the tile and end up in the hospital for a month afterwards. So something even minor like that. We had a kid who fell out of the bathtub. Normally, even with severe hemophilia, if they’re on prophy it wouldn’t create a devastating effect but that child had a devastating bleed in his head and was in the hospital for months. And so, you know, every bump and bruise becomes potentially life or death when they have an inhibitor. So you can imagine it just, severe hemophilia is already not a great thing and then you ramp it up to even more where your child can die from a minor event.

For more on the management of hemophilia, watch our latest video series here.

Related Videos
Diabetes patient turn knob on end of insulin pen and dial up correct insulin dose for injection. Scale window on pen syringe showing number of units dose. Medical equipment is easy to self injection - Image credit: Orawan | stock.adobe.com
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U - stock.adobe.com
Image credit: Krakenimages.com | stock.adobe.com
Human brain digital illustration. Electrical activity, flashes, and lightning on a blue background. | Image Credit: Siarhei - stock.adobe.com
Inflation Reduction Act is shown using the text and the US flag - Image credit: Andrii | stock.adobe.com
Pharmacy Interior | Image Credit: Tyler Olson - stock.adobe.com
Physician and kidneys
Image credit: gamjai - stock.adobe.com
Male pharmacist selling medications at drugstore to a senior woman customer | Image Credit: Zamrznuti tonovi - stock.adobe.com
© 2023 MJH Life Sciences

All rights reserved.